Literature DB >> 4852512

Intermittent cyclophosphamide in pemphigus vulgaris and bullous pemphigoid.

A Medved, I Maxwell.   

Abstract

Cyclophosphamide, given in widely spaced doses, was used in the treatment of a patient with pemphigus vulgaris and a patient with bullous pemphigoid. To our knowledge, this form of therapy has not previously been reported in these two diseases. The distinct advantages of the larger intermittent dose method of cyclophosphamide therapy over the more conventional daily dose regimen are discussed.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4852512      PMCID: PMC1947663     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  29 in total

1.  Corticosteroid treatment of pemphigus. Experience with fifty cases over a period of ten years.

Authors:  S L SANDERS; M BRODEY; C T NELSON
Journal:  Arch Dermatol       Date:  1960-11

Review 2.  Bullous pemphigoid. Is it an immunologic disease?

Authors:  W M Sams
Journal:  Arch Dermatol       Date:  1970-11

3.  Basement zone antibodies in bullous pemphigoid.

Authors:  R E Jordon; E H Beutner; E Witebsky; G Blumental; W L Hale; W F Lever
Journal:  JAMA       Date:  1967-05-29       Impact factor: 56.272

Review 4.  Cytotoxic drugs in treatment of nonmalignant diseases.

Authors: 
Journal:  Ann Intern Med       Date:  1972-04       Impact factor: 25.391

Review 5.  Immunosuppressants in the treatment of pemphigus.

Authors:  S Jablonska; T Chorzelski; M Blaszczyk
Journal:  Br J Dermatol       Date:  1970-08       Impact factor: 9.302

6.  Pemphigus vulgaris successfully treated with cyclophosphamide.

Authors:  A Ebringer; I R Mackay
Journal:  Ann Intern Med       Date:  1969-07       Impact factor: 25.391

7.  Treatment of pemphigus vulgaris with methotrexate.

Authors:  W F Lever; H S Goldberg
Journal:  Arch Dermatol       Date:  1969-07

8.  Alternate-day prednisone therapy for pemphigus vulgaris. Preliminary report.

Authors:  N B Rabhan; A W Kopf
Journal:  Arch Dermatol       Date:  1971-06

9.  Immunological aspects of candida infection complicating steroid and immunosuppressive drug therapy.

Authors:  P I Folb; J R Trounce
Journal:  Lancet       Date:  1970-11-28       Impact factor: 79.321

10.  Augmented incidence of neoplasia in female New Zealand black-New Zealand white (NZB-NZW) mice treated with long-term cyclophosphamide.

Authors:  S E Walker; G G Bole
Journal:  J Lab Clin Med       Date:  1971-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.